Changes to hepatitis B vaccine recommendations could leave millions of children vulnerable: Study
Originally published: October 21, 2026
By Ava Tsapatsaris and Dr. Betsy-Ann Assoumou
Changes to federal hepatitis B vaccination recommendations could lead to more childhood infections and leave up to 1.8 million young adults vulnerable to the virus, according to a new modeling study published in the Annals of Internal Medicine. The findings come as health experts raise concerns about the long-term effects of changing childhood vaccine recommendations.
▶ Watch the video: "Why the hepatitis B vaccine is safe and effective" (ABC News)
What is hepatitis B?
Hepatitis B is a viral infection that attacks the liver. It can cause a short-term illness or a lifelong (chronic) infection, according to the CDC. Many people have no symptoms, while others may have nausea, abdominal pain or jaundice (yellowing of the skin and eyes). It spreads through contact with infected blood and other bodily fluids.
Infants are especially vulnerable: about 90% of babies infected around the time of birth develop chronic hepatitis B, according to the American Academy of Pediatrics (AAP). Chronic infection can lead to serious complications, including liver damage and liver cancer. Dr. Alok Patel, a clinical associate professor of pediatrics at Stanford, notes that since routine vaccination at birth began in 1991, infant infections have reportedly dropped by 99%.
About the study
Researchers at Mass General Brigham used a computer model to follow a hypothetical group of 3.6 million babies born in the U.S. in 2026 through their first 20 years. For babies whose mothers test negative for hepatitis B during pregnancy, they compared three approaches:
Universal birth dose: the longstanding recommendation that every newborn gets the first dose shortly after birth.
Delayed dose: waiting until babies are at least 2 months old.
Shared clinical decision-making: parents and the child's provider decide together whether and when to vaccinate.
What did they find?
Compared with vaccinating all newborns at birth, delaying the first dose could increase chronic hepatitis B infections by 19% over 20 years, and the shared decision-making approach could increase them by 83%.
By age 20, about 232,000 children could remain unprotected under the universal birth dose approach, compared with 474,000 with delayed vaccination and 1.8 million with shared decision-making. These are children who would lack protection, not children who have the disease.
If high-risk babies (those born to mothers who test positive or whose status is unknown) were also less likely to be vaccinated, infections passed from mother to baby could double or triple over 20 years.
The researchers stress that these are estimates from a computer simulation, not actual infections. Corresponding author Dr. Amir Mohareb, an infectious disease physician at Mass General Brigham's Center for Global Health, says the findings support restoring the recommendation for universal hepatitis B vaccination at birth.
What changed, and where things stand
In December 2025, the CDC removed its longstanding recommendation that all newborns receive the hepatitis B vaccine at birth. Under that guidance, parents of babies born to mothers who test negative could decide with their provider whether to vaccinate at birth or start later, while babies born to mothers who are positive or whose status is unknown should still be vaccinated within 12 hours of birth.
In March 2026, a federal judge in Massachusetts stayed all votes taken by members of the CDC's vaccine advisory committee, including the removal of the universal birth dose recommendation. The CDC's website currently states that all infants should receive the hepatitis B vaccine, and the AAP continues to recommend a first dose within 24 hours of birth followed by the rest of the series.
Asked for comment, the Department of Health and Human Services pointed to a post from Secretary Robert F. Kennedy Jr. saying that HHS prioritizes informed consent, individual medical circumstances and conversations between parents and doctors, and that respecting parents' choices does not mean abandoning children's health.
Why doctors say the birth dose matters
Some physicians worry the changes have confused parents and could lead to fewer children being vaccinated. Patel explains that when a recommendation shifts from "every baby" to "let's discuss it," many families may hear that the vaccine is optional. Doctors note that the vaccine matters even when a mother tests negative, because babies can be exposed through infected caregivers. Delaying the first dose can also make it harder for some families to complete the series on schedule.
Because hepatitis B can go undetected for years, with serious complications sometimes appearing decades later, experts warn that even a small rise in childhood infections could have large health and economic effects down the road.
If you have questions about your child's vaccine schedule, talk with your pediatrician or healthcare provider.
This post is for general information and is not medical advice.
Source: Adapted from reporting by Ava Tsapatsaris and Dr. Betsy-Ann Assoumou for ABC News, "Changes to hepatitis B vaccine recommendations could leave millions of children vulnerable: Study," October 21, 2026. Dr. Betsy-Ann Assoumou is a family medicine resident and a member of the ABC News Medical Unit.





Comments